Doximity, Inc.

Profitability for 1 year: -31.75%
Dividend yield: 0%
Sector: Healthcare

Company Analysis Doximity, Inc.

Download the report: word Word pdf PDF

1. Summary

Advantages

  • Current debt level 0.98% is below 100% and has decreased over 5 years from 1.64%.
  • The company's current efficiency (ROE=20.62%) is higher than the sector average (ROE=-74.13%)

Disadvantages

  • Price (40.63 $) is higher than fair price (23.77 $)
  • Dividends (0%) are below the sector average (1.35%).
  • The stock's return over the last year (-31.75%) is lower than the sector average (-1.63%).

Similar companies

UnitedHealth Group

AbbVie

PFIZER

Johnson & Johnson

2. Share price and performance

2.1. Share price

2.3. Market efficiency

Doximity, Inc. Healthcare Index
7 days -1% 0% 0.5%
90 days -19.9% 5.9% 1.8%
1 year -31.7% -1.6% 13.2%

DOCS vs Sector: Doximity, Inc. has significantly underperformed the "Healthcare" sector by -30.11% over the past year.

DOCS vs Market: Doximity, Inc. has significantly underperformed the market by -44.99% over the past year.

Stable price: DOCS is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: DOCS with weekly volatility of -0.61% over the past year.

3. Summary of the report

3.1. General

P/E: 36.42
P/S: 14.25

3.2. Revenue

EPS 1.11
ROE 20.62%
ROA 17.65%
ROIC 28.12%
Ebitda margin 42.21%

5. Fundamental Analysis

5.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (40.63 $) is higher than the fair price (23.77 $).

Price is higher than fair: The current price (40.63 $) is 41.5% higher than the fair price.

5.2. P/E

P/E vs Sector: The company's P/E (36.42) is lower than that of the sector as a whole (142.07).

P/E vs Market: The company's P/E (36.42) is lower than that of the market as a whole (73.05).

5.2.1 P/E Similar companies

5.3. P/BV

P/BV vs Sector: The company's P/BV (7.51) is lower than that of the sector as a whole (18.06).

P/BV vs Market: The company's P/BV (7.51) is lower than that of the market as a whole (20.58).

5.3.1 P/BV Similar companies

5.5. P/S

P/S vs Sector: The company's P/S indicator (14.25) is lower than that of the sector as a whole (14.68).

P/S vs Market: The company's P/S indicator (14.25) is lower than that of the market as a whole (30.65).

5.5.1 P/S Similar companies

5.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (54.4) is lower than that of the sector as a whole (61.55).

EV/Ebitda vs Market: The company's EV/Ebitda (54.4) is higher than that of the market as a whole (36.29).

6. Profitability

6.1. Profitability and revenue

6.2. Earnings per share - EPS

6.3. Past profitability Net Income

Yield Trend: Rising and has grown by 69.27% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (69.27%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-72.41%).

6.4. ROE

ROE vs Sector: The company's ROE (20.62%) is higher than that of the sector as a whole (-74.13%).

ROE vs Market: The company's ROE (20.62%) is lower than that of the market as a whole (51.19%).

6.6. ROA

ROA vs Sector: The company's ROA (17.65%) is higher than that of the sector as a whole (6.62%).

ROA vs Market: The company's ROA (17.65%) is higher than that of the market as a whole (11.29%).

6.6. ROIC

ROIC vs Sector: The company's ROIC (28.12%) is higher than that of the sector as a whole (21.38%).

ROIC vs Market: The company's ROIC (28.12%) is lower than that of the market as a whole (45.07%).

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

7. Finance

7.1. Assets and debt

Debt level: (0.98%) is quite low in relation to assets.

Debt reduction: over 5 years, the debt has decreased from 1.64% to 0.98%.

Debt Covering: The debt is covered by 5.55% from net profit.

7.2. Profit growth and share price

8. Dividends

8.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '1.35%.

8.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

8.3. Payout percentage

Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

9. Insider trades

9.1. Insider trading

Insider Buying Exceeds insider sales by 20.28% over the last 3 months.

9.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
01.12.2025 Wampler Kira Scherer
Director
Sale 50.71 10 142 2 000
21.11.2025 TIMOTHY CABRAL
Director
Purchase 50 50 000 10 000
10.10.2025 REGINA M BENJAMIN
Director
Purchase 70.84 354 200 5 000
01.10.2025 KIRA WAMPLER
Director
Purchase 70.01 140 020 2 000
24.09.2025 Cabral Timothy S
Director
Sale 75 1 500 000 20 000